DK52875A - - Google Patents

Info

Publication number
DK52875A
DK52875A DK52875*#A DK52875A DK52875A DK 52875 A DK52875 A DK 52875A DK 52875 A DK52875 A DK 52875A DK 52875 A DK52875 A DK 52875A
Authority
DK
Denmark
Application number
DK52875*#A
Other languages
Danish (da)
Other versions
DK143247C (da
DK143247B (da
Inventor
A J Torode
D Harden
J Spence
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK52875(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK52875A publication Critical patent/DK52875A/da
Publication of DK143247B publication Critical patent/DK143247B/da
Application granted granted Critical
Publication of DK143247C publication Critical patent/DK143247C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK52875A 1974-02-14 1975-02-13 Medicinsk tablet indeholdende som aktiv bestanddel en 2,4-diamino-5-benzylpyrimidin sammen med et sulfonamid DK143247C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB675874 1974-02-14
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (3)

Publication Number Publication Date
DK52875A true DK52875A (en:Method) 1975-10-06
DK143247B DK143247B (da) 1981-08-03
DK143247C DK143247C (da) 1981-11-30

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
DK52875A DK143247C (da) 1974-02-14 1975-02-13 Medicinsk tablet indeholdende som aktiv bestanddel en 2,4-diamino-5-benzylpyrimidin sammen med et sulfonamid

Country Status (32)

Country Link
JP (1) JPS5545043B2 (en:Method)
AT (1) AT344915B (en:Method)
AU (1) AU468465B2 (en:Method)
BE (1) BE825496A (en:Method)
CA (1) CA980688A (en:Method)
CH (1) CH618432A5 (en:Method)
CS (1) CS220306B2 (en:Method)
CY (1) CY1052A (en:Method)
DD (1) DD118228A5 (en:Method)
DE (1) DE2506099C2 (en:Method)
DK (1) DK143247C (en:Method)
DO (1) DOP1979002763A (en:Method)
ES (1) ES434688A1 (en:Method)
FI (1) FI62219C (en:Method)
FR (1) FR2260993B1 (en:Method)
GB (1) GB1499672A (en:Method)
GT (1) GT197960431A (en:Method)
HK (1) HK23980A (en:Method)
HU (1) HU171536B (en:Method)
IE (1) IE40599B1 (en:Method)
IL (1) IL46629A (en:Method)
IN (1) IN141019B (en:Method)
KE (1) KE3038A (en:Method)
LU (1) LU71835A1 (en:Method)
MC (1) MC1053A1 (en:Method)
MY (1) MY8100054A (en:Method)
NL (1) NL157501C (en:Method)
NO (1) NO146043C (en:Method)
PH (1) PH14575A (en:Method)
SE (1) SE427898B (en:Method)
ZA (1) ZA75930B (en:Method)
ZM (1) ZM1875A1 (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
DE2506099A1 (de) 1975-08-21
NL157501C (nl) 1981-07-16
DK143247C (da) 1981-11-30
CA980688A (en) 1975-12-30
DK143247B (da) 1981-08-03
CY1052A (en) 1980-08-01
NO146043B (no) 1982-04-13
IL46629A0 (en) 1975-05-22
DD118228A5 (en:Method) 1976-02-20
LU71835A1 (en:Method) 1975-06-24
HU171536B (hu) 1978-01-28
FI62219C (fi) 1982-12-10
CS220306B2 (en) 1983-03-25
AU468465B2 (en) 1976-01-15
FI750398A7 (en:Method) 1975-08-15
PH14575A (en) 1981-09-24
AU7817075A (en) 1976-01-15
BE825496A (fr) 1975-05-29
NO146043C (no) 1982-08-04
IE40599L (en) 1975-08-14
SE427898B (sv) 1983-05-24
NL7501680A (nl) 1975-08-18
MC1053A1 (fr) 1976-02-20
FI62219B (fi) 1982-08-31
CH618432A5 (en) 1980-07-31
ZA75930B (en) 1976-01-28
IE40599B1 (en) 1979-07-04
GT197960431A (es) 1981-05-05
IN141019B (en:Method) 1977-01-08
KE3038A (en) 1980-04-25
FR2260993B1 (en:Method) 1978-06-30
FR2260993A1 (en:Method) 1975-09-12
NO750467L (en:Method) 1975-08-15
SE7501595L (en:Method) 1975-08-15
ES434688A1 (es) 1977-04-01
JPS50116627A (en:Method) 1975-09-12
HK23980A (en) 1980-05-09
ZM1875A1 (en) 1975-12-22
JPS5545043B2 (en:Method) 1980-11-15
GB1499672A (en) 1978-02-01
ATA108475A (de) 1977-12-15
DE2506099C2 (de) 1983-11-03
IL46629A (en) 1977-07-31
AT344915B (de) 1978-08-25
MY8100054A (en) 1981-12-31
DOP1979002763A (es) 1987-06-18
NL157501B (nl) 1978-08-15

Similar Documents

Publication Publication Date Title
FR2260139A1 (en:Method)
DK148975A (en:Method)
FR2260993B1 (en:Method)
FR2260200A1 (en:Method)
FR2256759A1 (en:Method)
CS162592B1 (en:Method)
AU7474374A (en:Method)
AU7138274A (en:Method)
CS167177B1 (en:Method)
AU6599774A (en:Method)
DE2426557A1 (en:Method)
BG19768A1 (en:Method)
BG20149A1 (en:Method)
DD120624A5 (en:Method)
BG19866A1 (en:Method)
BG19774A1 (en:Method)
BG19899A1 (en:Method)
DD116175A1 (en:Method)
BG19905A1 (en:Method)
BG20474A1 (en:Method)
BG19993A1 (en:Method)
BG20039A1 (en:Method)
BG19703A1 (en:Method)
BG19621A1 (en:Method)
BG19564A1 (en:Method)

Legal Events

Date Code Title Description
PUP Patent expired